Skip to content

An Evaluation of the Effect of the AmnioFix Amniotic Membrane Allograft in Patients Undergoing Posterior Instrumentation Removal

An Evaluation of the Effect of the AmnioFix™ Amniotic Membrane Allograft on Scar Tissue and Adhesions in Patients Undergoing Posterior Instrumentation Removal

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01357187
Enrollment
5
Registered
2011-05-20
Start date
2011-09-30
Completion date
2014-05-31
Last updated
2015-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesions of Soft Tissue

Keywords

Lumbar pathology, requiring elective lumbar interbody fusion

Brief summary

The objective of this study is to evaluate the clinical effectiveness of AmnioFix™ in the reduction of the tenacity and frequency of soft tissue adhesions during the removal of segmental posterior lumbar instrumentation.

Interventions

OTHERScheduled removal of posterior instrumentation with AmnioFix
OTHERScheduled removal of posterior instrumentation without AmnioFix

Sponsors

MiMedx Group, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (18 years or older) * Diagnosed with lumbar pathology requiring elective lumbar interbody fusion * Willingness to comply to follow-up examinations and diagnostic imaging procedures * Ability to give full written informed consent

Exclusion criteria

* Previous surgical procedure performed at same site * Sign or symptoms of other disease which could result in allograft failure * Require a corpectomy * Participating in another drug or device clinical trial * Pregnant or may become pregnant during the study * Prisoner * Involved in workmen's compensation or other litigation relative to a spine injury * Past medical history of allograft implantation which resulted in graft failure * Any condition requiring treatment above the normal standard of care * Currently taking medications which could affect graft incorporation (supervising physicians discretion) * Auto-Immune disease * Renal failure * Failure to sign or understand informed consent information * History of drug and/or alcohol abuse * Allergic to aminoglycosides

Design outcomes

Primary

MeasureTime frame
Tenacity and frequency of soft tissue adhesionAt the time of removal of segmental posterior lumbar instrumentation

Secondary

MeasureTime frame
Presence and extent of scar tissue using histological analysis of the lumbar tissue adjacent to the surgical siteAt the time of removal of segmental posterior lumbar instrumentation
Number of intra-operative complicationsAt the time of removal of segmental posterior lumbar instrumentation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026